These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 14985462

  • 1. Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: novel strategies for colon cancer prevention and treatment.
    Swamy MV, Cooma I, Patlolla JM, Simi B, Reddy BS, Rao CV.
    Mol Cancer Ther; 2004 Feb; 3(2):215-21. PubMed ID: 14985462
    [Abstract] [Full Text] [Related]

  • 2. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS.
    Cancer Res; 2002 Jan 01; 62(1):165-70. PubMed ID: 11782374
    [Abstract] [Full Text] [Related]

  • 3. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S, Tegeder I, Niederberger E, Bräutigam L, Geisslinger G.
    FASEB J; 2001 Dec 01; 15(14):2742-4. PubMed ID: 11606477
    [Abstract] [Full Text] [Related]

  • 4. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
    Swamy MV, Cooma I, Reddy BS, Rao CV.
    Int J Oncol; 2002 Apr 01; 20(4):753-9. PubMed ID: 11894121
    [Abstract] [Full Text] [Related]

  • 5. Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells.
    Narayanan BA, Narayanan NK, Desai D, Pittman B, Reddy BS.
    Carcinogenesis; 2004 Dec 01; 25(12):2443-9. PubMed ID: 15297372
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53.
    Swamy MV, Herzog CR, Rao CV.
    Cancer Res; 2003 Sep 01; 63(17):5239-42. PubMed ID: 14500353
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M, Tsuji S, Tsujii M, Irie T, Komori M, Kimura A, Nishida T, Kakiuchi Y, Kawai N, Murata H, Horimoto M, Sasaki Y, Hayashi N, Kawano S, Hori M.
    Cancer Res; 2003 Oct 15; 63(20):6726-34. PubMed ID: 14583467
    [Abstract] [Full Text] [Related]

  • 8. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids.
    Reddy BS, Patlolla JM, Simi B, Wang SH, Rao CV.
    Cancer Res; 2005 Sep 01; 65(17):8022-7. PubMed ID: 16140976
    [Abstract] [Full Text] [Related]

  • 9. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N.
    Clin Cancer Res; 2005 Sep 15; 11(18):6738-44. PubMed ID: 16166455
    [Abstract] [Full Text] [Related]

  • 10. A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors.
    Narayanan NK, Narayanan BA, Reddy BS.
    Int J Oncol; 2005 Mar 15; 26(3):785-92. PubMed ID: 15703837
    [Abstract] [Full Text] [Related]

  • 11. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV.
    Cancer Res; 2000 Jan 15; 60(2):293-7. PubMed ID: 10667579
    [Abstract] [Full Text] [Related]

  • 12. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
    Liu W, Chen Y, Wang W, Keng P, Finkelstein J, Hu D, Liang L, Guo M, Fenton B, Okunieff P, Ding I.
    Am J Clin Oncol; 2003 Aug 15; 26(4):S103-9. PubMed ID: 12902866
    [Abstract] [Full Text] [Related]

  • 13. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, Noguchi K, Sakurai K.
    Int J Oncol; 2003 Sep 15; 23(3):665-72. PubMed ID: 12888902
    [Abstract] [Full Text] [Related]

  • 14. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS, Davis TW, Ornberg RL, Masferrer JL.
    Cancer Res; 2002 Nov 15; 62(22):6706-11. PubMed ID: 12438270
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma.
    Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ.
    Cancer Res; 2004 Feb 01; 64(3):1181-9. PubMed ID: 14871855
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Correspondence re: M. V. Swamy et al., Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53. Cancer Res 2003;63:5239-42.
    Schönthal AH.
    Cancer Res; 2004 Apr 15; 64(8):2937; author reply 2938. PubMed ID: 15087416
    [No Abstract] [Full Text] [Related]

  • 18. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
    Kusunoki N, Yamazaki R, Kawai S.
    Arthritis Rheum; 2002 Dec 15; 46(12):3159-67. PubMed ID: 12483719
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.